Key Metrics of Dexcom
Revenue$3.6B▲ 24.5% YoYFY 2023
Operating income$598M▲ 52.8% YoY
Net profit$542M▲ 58.7% YoY
Shareholders' equity$2.1B
Market cap$29.6BDXCM · $78.32
About Dexcom
Company details
- Website
- dexcom.com
- Founded
- 2005
- Listed
- Nasdaq: DXCM (since 2005)
Company summary
Legal nameDexCom Inc.
TickerDXCM
ExchangeNasdaq
CountryUnited States
SEC CIK0001093557
Listed since2005
IndustryMedical/Dental Instruments
SectorOther Industries · Discovered Companies
Websitehttp://dexcom.com
US market & SEC filings
DXCM · Nasdaq · SEC CIK 0001093557
Last price · 24 Oct 2026
$78.32
−2.42%
Market cap$29.6B
P/E60.2On FY 2023 diluted EPS
Volume10,794,304
SectorHealth CareMedical/Dental Instruments
Country · IPOUnited StatesListed 2005
DXCM share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeSan Diego
GSTIN—
Email—
Websitehttp://dexcom.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.